Albendazole

Active ingredient description

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Albendazole
P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Medicines

Albendazole is the active ingredient of these drugs:

Drug
Countries

Ecuador

Brazil

Singapore

Ecuador

Brazil

Estonia United States

Ecuador

Singapore

Turkey

Estonia Lithuania Turkey

Ecuador

Ecuador

South Africa

Ecuador

Romania

Australia Austria Estonia France Lithuania

Ecuador

Turkey

Ecuador

Ecuador

Ecuador

Lithuania

Brazil

Brazil

Tunisia

South Africa

South Africa

Brazil

Ecuador

Ecuador

Romania

Ecuador

Ecuador

South Africa

Tunisia

Tunisia

Australia Ecuador France Mexico Poland

Cyprus

Brazil

Albendazole is also found within below combination drugs:

ASCARAMEB , LOXCELL NF , OXAL , PARASI-KIT , PARASIPACK , PAZIDOL 1-2 , PROTHELMINT

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₂H₁₅N₃O₂S
Molecular mass: 265.331 g/mol

External identifiers

CAS Substance: 54965-21-8
DrugBank Drug: DB00518
KEGG Drug: D00134
PubChem Compound: 2082
RxNorm Ingredient: 430
SNOMED-CT Concept: 387558006
Albendazole (substance)
UNII Identifier: F4216019LN
ALBENDAZOLE